Nishino Masami, Yano Masamichi, Ukita Kohei, Kawamura Akito, Nakamura Hitoshi, Matsuhiro Yutaka, Yasumoto Koji, Tsuda Masaki, Okamoto Naotaka, Tanaka Akihiro, Matsunaga-Lee Yasuharu, Egami Yasuyuki, Shutta Ryu, Tanouchi Jun, Yamada Takahisa, Yasumura Yoshio, Tamaki Shunsuke, Hayashi Takaharu, Nakagawa Akito, Nakagawa Yusuke, Suna Shinichiro, Nakatani Daisaku, Hikoso Shungo, Sakata Yasushi
Division of Cardiology, Osaka Rosai Hospital, 1179-3, Nagasonecho, Kita-ku, Sakai, Osaka, 591-8025, Japan.
Division of Cardiology, Osaka General Medical Center, Osaka, Japan.
ESC Heart Fail. 2021 Jun;8(3):2120-2132. doi: 10.1002/ehf2.13293. Epub 2021 Mar 10.
Heart failure (HF) readmissions with preserved ejection fraction (HFpEF) are increasing in the elderly, which is a major socioeconomic problem. We investigated the clinical impact of HF readmissions (HFR) on octogenarians with HFpEF.
We enrolled consecutive octogenarians (≥80 years old) from June 2016 to February 2020 in PURSUIT-HFpEF registry. We divided them into HFR group readmitted for HF during the follow-up period and non-HF readmission (non-HFR) group. We evaluated the impact of HFR on all-cause mortality, cardiac death, and quality of life (QOL). Additionally, we evaluated the factors at discharge correlated with HFR. HFR group comprised 116 patients (21.4%). Among all-cause deaths, 40 patients suffered cardiac deaths (48.2%). The Kaplan-Meier analysis revealed a similar prognosis between HFR and non-HFR groups as well as similar incidences of HF deaths. The QOL scores had significantly deteriorated by 1 year later in the HFR group (0.71 ± 0.19 vs. 0.59 ± 0.21, P < 0.001), while it was similar at 1 year in the non-HFR group. In the multivariate analysis, diabetes mellitus (DM) (P = 0.019), N-terminal pro-B-type natriuretic peptide (NT-pro BNP) levels ≥ 1611 pg/mL (P < 0.001), and serum albumin level ≤ 3.7 g/dL (P = 0.011) were useful markers for HFR in octogenarians.
In octogenarians with HFpEF, HF readmission was not directly correlated with the prognosis but was well correlated with the QOL. Close follow-up is essential to decrease HFR of octogenarians with HFpEF with DM, high NT-pro BNP (≥1611 pg/mL) and low albumin (≤3.7 g/dL) levels at discharge.
射血分数保留的心力衰竭(HFpEF)患者再次入院在老年人中呈上升趋势,这是一个重大的社会经济问题。我们调查了HF再入院(HFR)对患有HFpEF的八旬老人的临床影响。
我们纳入了2016年6月至2020年2月连续入选PURSUIT-HFpEF登记处的八旬老人(≥80岁)。我们将他们分为随访期间因HF再次入院的HFR组和非HF再入院(非HFR)组。我们评估了HFR对全因死亡率、心源性死亡和生活质量(QOL)的影响。此外,我们评估了出院时与HFR相关的因素。HFR组包括116例患者(21.4%)。在全因死亡中,40例患者死于心源性死亡(48.2%)。Kaplan-Meier分析显示HFR组和非HFR组之间的预后相似,心源性死亡发生率也相似。HFR组1年后QOL评分显著恶化(0.71±0.19对0.59±0.21,P<0.001),而非HFR组1年时相似。多因素分析中,糖尿病(DM)(P=0.019)、N末端B型利钠肽原(NT-pro BNP)水平≥1611 pg/mL(P<0.001)和血清白蛋白水平≤3.7 g/dL(P=0.011)是八旬老人HFR的有用标志物。
在患有HFpEF的八旬老人中,HF再入院与预后无直接相关性,但与QOL密切相关。对出院时患有DM、NT-pro BNP高(≥1611 pg/mL)和白蛋白低(≤3.7 g/dL)的HFpEF八旬老人,密切随访对于降低HFR至关重要。